NEW YORK, NY — As Breast Cancer Awareness Month unfolds each October, the skyline of the world is often dominated by a singular shade of pink. However, for those living with metastatic breast cancer (MBC)—also known as Stage 4—the conversation often feels incomplete. While the broader awareness movement frequently highlights early detection and the conclusion of treatment, the reality for thousands is a chronic, life-altering battle against a disease that, currently, has no cure.
On October 13, National Metastatic Breast Cancer Awareness Day, the organization METAvivor Research and Support is spearheading a monumental effort to shift the narrative. Through its global #LightUpMBC campaign, more than 325 landmarks across 20 countries, 195 cities, and all 50 U.S. states will be bathed in the signature teal, green, and pink lights of the MBC community. This initiative is not merely a visual spectacle; it is a desperate, strategic call for the funding of critical research that aims to transform a terminal diagnosis into a manageable, long-term condition.
The Reality of Stage 4: Defining the Invisible Struggle
Metastatic breast cancer occurs when cancer cells migrate from the primary site in the breast to distant areas of the body, most frequently the bones, liver, lungs, or brain. It is crucial to understand that even when the cancer spreads to these vital organs, it remains classified as breast cancer.
For some, this is their initial diagnosis; for others, it is a devastating recurrence that emerges months, years, or even decades after the successful treatment of early-stage disease. Unlike non-metastatic forms of the disease, Stage 4 breast cancer is characterized by ongoing treatment. There is no “end” to the protocol. Even when advanced medical imaging shows no evidence of disease, it does not imply a cure. Instead, the objective of modern medicine is to control the spread, extend the patient’s life, and maintain a standard of living that allows for the preservation of daily joy.
The challenges are compounded by the biological nature of the disease: cancer cells are notoriously adaptive. They can develop resistance to existing therapies, forcing patients to endure the physical and emotional toll of switching medications repeatedly. The statistical weight of this crisis is sobering. In the United States alone, an estimated 42,670 people are projected to succumb to breast cancer in 2026—a harrowing average of approximately 117 deaths every single day.
A Chronology of Advocacy: From One Bridge to a Global Beacon
The origins of #LightUpMBC are rooted in personal loss and the desire to change the future. The campaign was founded by Laura Inahara, who drew her inspiration from her late best friend, Jessica Moore. Moore, who lost her life to metastatic breast cancer at the age of 36, harbored a simple, poignant dream: to see one local landmark illuminated to honor the thousands of women and men facing this diagnosis.
What began as a localized act of remembrance has evolved into a global phenomenon.
- 2017: The movement saw its first milestone when the Memorial Bridge in Portsmouth, New Hampshire, became the inaugural landmark to light up in the colors of MBC awareness.
- 2020–2025: The campaign scaled rapidly, moving from regional recognition to international participation. By leveraging social media and grassroots organizing, the movement connected families, advocates, and patients across borders.
- 2026: The campaign hits a record-breaking scale, with over 325 landmarks, including world-renowned sites like One World Trade Center in New York City, the Willis Tower in Chicago, Philadelphia City Hall, Niagara Falls, and the Ness Bridge in Scotland.
This progression represents more than just geographical reach; it signifies a growing public understanding that the "pink ribbon" narrative requires a deeper, more nuanced layer of support specifically for those facing advanced disease. To date, the #LightUpMBC initiative has successfully raised over $2.7 million, with every dollar of net proceeds funneled directly into research grants.
Scientific Rigor and Patient-Led Priorities
METAvivor stands apart in the nonprofit sector because it exclusively funds Stage 4 research. The organization recognizes that while early detection research is vital, the immediate survival of those currently living with metastatic disease depends on breakthroughs in systemic treatment.
The grant-making process at METAvivor is uniquely designed to bridge the gap between cold clinical data and the lived experience of patients. Every research project undergoes a dual-layer review process:
- Scientific Peer Review: Ensuring that the proposed methodology is sound, innovative, and holds promise for clinical application.
- Patient Advocate Review: Ensuring that the research addresses the actual needs and quality-of-life concerns of those who will ultimately benefit from these therapies.
This approach ensures that the funds raised through #LightUpMBC are not just fueling theoretical science, but are targeted toward projects that could realistically transform MBC from a terminal diagnosis into a manageable, chronic condition.
Voices of Resilience: Official Perspectives
The human element of this campaign is perhaps best captured by Dr. Kelly Shanahan, the Board President of METAvivor. Diagnosed with MBC in 2013, Dr. Shanahan’s survival is a testament to the power of medical progress.
"When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan remarked. "My hope and the hope of so many others lies in research, and METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research, and it is also a way to bring us together as a community."
Founder Laura Inahara reflects on the legacy of the woman who sparked this global movement. "Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teaches patients with MBC how to advocate for themselves, and has now raised over $2.7 million for critical MBC research."
LightUpMBC Live: A Global Virtual Stage
The culmination of the day’s activities is the #LightUpMBC Live broadcast, an event designed to bring the global community together at 8 p.m. ET / 5 p.m. PT on October 13. The broadcast will be hosted by Tami Eagle Bowling, who has lived with MBC for 11 years, and Broadway performer and breast cancer survivor Kara Lindsay.
The event promises to be a powerful blend of advocacy and art. Viewers can tune in via the METAvivor YouTube channel, Facebook Live, or the LiveOne platform. The program features:
- Patient Narratives: Raw, authentic stories shared directly from the sites of illuminated landmarks.
- Clinical Insight: Discussions with leading researchers regarding the latest developments in Stage 4 treatment.
- Performative Tributes: Musical contributions from Broadway luminaries, including two-time Tony Award winner Victoria Clark, Tony Award nominee Dorian Harewood, actress Christina Bianco, singer-songwriter Cassandra Kubinski, and voiceover artist Tony Daniels.
Implications for the Future of Care
The success of the #LightUpMBC campaign highlights a significant shift in public health advocacy. By refusing to let the complexities of metastatic cancer be glossed over by general awareness campaigns, advocates are successfully forcing a conversation about long-term survival, palliative care, and the necessity of targeted research funding.
The implications are clear: the more the public understands the distinction between early-stage breast cancer and metastatic breast cancer, the more pressure is placed on pharmaceutical companies, government funding bodies, and private donors to prioritize the most vulnerable patients.
As the lights turn on across the globe this October 13, the goal is not just to create a beautiful visual, but to ensure that the "light" becomes a symbol of sustained, year-round commitment to those who are fighting for every additional day. The movement invites all to participate by photographing their local landmarks, sharing them on social media with the tags #LightUpMBC and #METAvivor, and contributing to the research that remains the only bridge to a future without the threat of Stage 4 breast cancer.
For more information on the campaign, to locate a participating landmark near you, or to make a contribution, visit www.lightupmbc.org. Every contribution serves as an investment in the lives of those currently navigating the complexities of metastatic breast cancer.
About the Author
